HealthDay - "Study Weighs Safety of Epilepsy Drugs in Pregnancy"

Levetiracetam appears to pose low risk for baby, but there's more evidence of risk with valproate.

New York, NY
 – January 8, 2014  –– 

New British research suggests that the epilepsy drug levetiracetam does not pose a major risk to the neurological development of the fetus, although there's more evidence that another drug – valproate – may cause problems. Keith Eddleman, MD, Professor of Obstetrics, Gynecology and Reproductive Sciences, Genetics and Genomic Sciences, and Director of Obstetrics at the Mount Sinai Health System weighs in. Learn more